Sabby Management’s CervoMed CRVO Stock Holding History

Sabby Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$772K	Buy	+248,880	New	+$877K	0.7%	10
2020 Q1	–	Sell	-14,473	Closed	-$500K	–	92
2019 Q4	$500K	Buy	14,473 +8,235	+132%	+$503K	0.14%	35
2019 Q3	$865K	Sell	6,238 -10	-0.2%	-$1.61K	0.47%	26
2019 Q2	$1.34M	Buy	+6,248	New	+$1.68M	1.68%	14

Other funds holding CRVO

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $185M AUM 41.05% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $8.3B AUM 27.66% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return

SAI

Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return

Sabby Management's CRVO Position: Q2 2026 in Review

Sabby Management opened a new position in CervoMed (CRVO) in Q2 2026: 248,880 shares worth $772K. The stake represents 0.7% of the portfolio and ranks #10 among its holdings. This is a return to the name: Sabby Management previously reported a position in CRVO as recently as Q4 2019.

Sabby Management first reported a position in CRVO in Q2 2019 and has held it in 4 quarters since. The position peaked at $1.34M in Q2 2019. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

Sabby Management held 248,880 shares of CervoMed worth $772K as of Q2 2026.
CervoMed was a new Sabby Management position in Q2 2026.
CervoMed made up 0.7% of Sabby Management's portfolio in Q2 2026, its #10 holding.
Sabby Management first reported a position in CervoMed in Q2 2019 and has held it in 4 quarters since.
Sabby Management's CervoMed position peaked at $1.34M in Q2 2019.
37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.